IDEAYA Biosciences, Inc. (IDYA) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2017: -$12.22M2018: -$27.62M2019: -$39.31M2020: $55.46M2021: -$55.78M2022: -$87.17M2023: -$115.22M2024: -$247.58M2025: -$71.10M-$71.10M
2017Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$71.10M+71.3%
2024-$247.58M-114.9%
2023-$115.22M-32.2%
2022-$87.17M-56.3%
2021-$55.78M-200.6%
2020$55.46M+241.1%
2019-$39.31M-42.3%
2018-$27.62M-125.9%
2017-$12.22M